Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
YS Biopharma Co Ltd banner

YS Biopharma Co Ltd
NASDAQ:LSB

Watchlist Manager
YS Biopharma Co Ltd Logo
YS Biopharma Co Ltd
NASDAQ:LSB
Watchlist
Price: 0.627 USD -24.46% Market Closed
Market Cap: $25.8m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
-
5Y
-
10Y
-
Liabilities
+
3Y
-
5Y
-
10Y
-
Equity
+
3Y
-
5Y
-
10Y
-

Balance Sheet Decomposition
YS Biopharma Co Ltd

Balance Sheet
YS Biopharma Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Mar-2022 Mar-2023 Mar-2024 Mar-2025
Assets
Cash & Cash Equivalents
271
370
246
28
Cash
271
370
246
28
Short-Term Investments
3
4
4
3
Total Receivables
313
468
447
502
Accounts Receivables
309
463
444
501
Other Receivables
4
5
3
1
Inventory
167
185
203
228
Other Current Assets
12
8
2
81
Total Current Assets
765
1 036
903
842
PP&E Net
565
583
481
414
PP&E Gross
565
583
481
414
Accumulated Depreciation
180
209
316
320
Intangible Assets
81
78
71
73
Other Long-Term Assets
31
23
58
38
Total Assets
1 442
N/A
1 720
+19%
1 513
-12%
1 368
-10%
Liabilities
Accounts Payable
31
80
68
50
Accrued Liabilities
228
266
281
276
Short-Term Debt
0
0
0
0
Current Portion of Long-Term Debt
112
194
319
390
Other Current Liabilities
106
118
135
109
Total Current Liabilities
476
659
802
825
Long-Term Debt
254
294
99
24
Other Liabilities
41
39
27
20
Total Liabilities
771
N/A
991
+29%
928
-6%
868
-6%
Equity
Common Stock
1 370
0
0
0
Retained Earnings
1 591
1 874
2 308
2 407
Additional Paid In Capital
809
2 657
2 951
2 964
Other Equity
83
54
58
57
Total Equity
671
N/A
728
+9%
585
-20%
500
-15%
Total Liabilities & Equity
1 442
N/A
1 720
+19%
1 513
-12%
1 368
-10%
Shares Outstanding
Common Shares Outstanding
9
9
19
21

See Also

Summary
LSB intrinsic value, competitors valuation, and company profile.
DCF Valuation
LSB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LSB stock valuation using valuation multiples.
Wall Street Estimates
LSB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LSB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 317,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.